---
figid: PMC4546915__nihms655439f1
figtitle: Adaptive stress signaling in targeted therapy resistance in cancer
organisms:
- Homo sapiens
- Mus musculus
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4546915
filename: nihms655439f1.jpg
figlink: /pmc/articles/PMC4546915/figure/F1/
number: F1
caption: 'Shown are major signaling pathways involved in the initiation and progression
  of many tumors. Pathway crosstalk can occur at multiple levels from signaling emanating
  from the plasma membrane to the mitochondrial and nuclear events. Thus, there is
  significant potential for stress response signaling such that inhibition of one
  pathway results in the engagement of a distinct pathway that maintains tumor cell
  homeostasis and promotes escape from therapy. This profound robustness is a critical
  feature of the evolution of tumors both in the absence and the presence of therapy,
  consistently enhancing tumor survival in response to various stresses. Abbreviations:
  Raf, Raf proto-oncogene serine/threonine kinase; Mek, mitogen activated protein
  kinase kinase; Erk, extracellular signal related kinase; PI3K, phosphoinositide
  3-kinase; AKT, v-akt murine thymoma viral oncogene homolog; IRS1, insulin receptor
  substrate; mTORC1/2, mammalian target of rapamycin; GRB2, growth factor receptor-bound
  protein; SOS, son of sevenless homolog; PTEN, phosphatase and tensin homolog; PDPK1,
  3-phosphoinositide dependent protein kinase 1, TSC1/2, tuberus sclerosis; PLC, phospholipase
  C; RalGDS, ral guanine nucleotide dissociation stimulator; IKKα/β, inhibitor of
  nuclear factor kappa-B kinase subunit alpha/beta. NFκB, nuclear factor kappa-light-chain-enhancer
  of activated B cells'
papertitle: Adaptive stress signaling in targeted therapy resistance in cancer.
reftext: Evangelos Pazarentzos, et al. Oncogene. 2015 Nov 5;34(45):5599-5606.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9583516
figid_alias: PMC4546915__F1
figtype: Figure
redirect_from: /figures/PMC4546915__F1
ndex: 40a5f8b2-dee4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4546915__nihms655439f1.html
  '@type': Dataset
  description: 'Shown are major signaling pathways involved in the initiation and
    progression of many tumors. Pathway crosstalk can occur at multiple levels from
    signaling emanating from the plasma membrane to the mitochondrial and nuclear
    events. Thus, there is significant potential for stress response signaling such
    that inhibition of one pathway results in the engagement of a distinct pathway
    that maintains tumor cell homeostasis and promotes escape from therapy. This profound
    robustness is a critical feature of the evolution of tumors both in the absence
    and the presence of therapy, consistently enhancing tumor survival in response
    to various stresses. Abbreviations: Raf, Raf proto-oncogene serine/threonine kinase;
    Mek, mitogen activated protein kinase kinase; Erk, extracellular signal related
    kinase; PI3K, phosphoinositide 3-kinase; AKT, v-akt murine thymoma viral oncogene
    homolog; IRS1, insulin receptor substrate; mTORC1/2, mammalian target of rapamycin;
    GRB2, growth factor receptor-bound protein; SOS, son of sevenless homolog; PTEN,
    phosphatase and tensin homolog; PDPK1, 3-phosphoinositide dependent protein kinase
    1, TSC1/2, tuberus sclerosis; PLC, phospholipase C; RalGDS, ral guanine nucleotide
    dissociation stimulator; IKKα/β, inhibitor of nuclear factor kappa-B kinase subunit
    alpha/beta. NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - Grb2
  - Pten
  - Pdpk1
  - Irs1
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Mtor
  - Ralgds
  - Hspg2
  - Zhx2
  - Rictor
  - Mlst8
  - Rala
  - Ralb
  - Mdk
  - Tsc2
  - Tsc1
  - Akt1s1
  - Ksr1
  - Exoc2
  - Ephb2
  - Mapk1
  - Tbk1
  - Rptor
  - Cdc42
  - Nfkb1
  - Gsk3b
  - Tbc1d4
  - Bad
  - Casp9
  - Fos
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Trp53
  - Mdm2
  - Pfkfb3
  - Nos3
  - Xiap
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - PTEN
  - PDPK1
  - IRS1
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - RALGDS
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RALA
  - RALB
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TSC2
  - TSC1
  - CCL26
  - AKT1S1
  - KSR1
  - KSR2
  - EXOC2
  - EPHB2
  - MAPK1
  - MAPK3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - RPTOR
  - TBK1
  - CDC42
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MYC
  - GSK3A
  - GSK3B
  - TBC1D4
  - ETS1
  - ETS2
  - BAD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - FOS
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - TP53
  - TP63
  - TP73
  - MDM2
  - PFKFB3
  - NOS3
  - ENO4
  - XIAP
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Sos
  - drk
  - Pdk1
  - Akt
  - Ras64B
  - Ras85D
  - Tor
  - Rgl
  - norpA
  - sl
  - Plc21C
  - Raf
  - rictor
  - Lst8
  - Dsor1
  - Mtk
  - gig
  - PRAS40
  - ksr
  - Sec5
  - Erk7
  - rl
  - Rlip
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Crtc
  - raptor
  - IKKepsilon
  - key
  - IKKbeta
  - Dif
  - dl
  - Rel
  - Myc
  - sgg
  - Ets21C
  - Ets65A
  - pnt
  - Ets96B
  - Ets97D
  - Ets98B
  - cass
  - Dronc
  - kay
  - dap
  - DCTN6-p27
  - CG9588
  - CycE
  - cyc
  - p53
  - betaTub60D
  - hth
  - Glucose
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
